UniProt Q9NR12
Isoform 4 of PDZ and LIM domain protein 7,Sorting nexin-17 fusion (Q9NR12)
Isoform 4 of PDZ and LIM domain protein 7,Sorting nexin-17 fusion (UniProt Q9NR12): 4 experimental structures and 1 predicted model on GenesisL1, 3 pockets. Binding sites, druggability and experiment against prediction (TM-score)…
- UniProt
- Q9NR12
- Protein
- Isoform 4 of PDZ and LIM domain protein 7,Sorting nexin-17 fusion
- Experimental structures
- 4
- Predicted models
- 1
- Pockets
- 3 · 1 record with a druggable one
Structures
5 records of Q9NR12 in the MolNFT archive: 4 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2Q3G | Structure of the PDZ domain of human PDLIM7 bound to a C-terminal extension from human… | x-ray diffraction | A, B | — | — |
| 2Q3G | Structure of the PDZ domain of human PDLIM7 bound to a C-terminal extension from human… | x-ray diffraction | A, B | — | — |
| 7RM8 | Solution NMR structure of PDLIM7 PDZ bound to SNX17 peptide | solution nmr | A | — | 1 (best 0.28) |
| 7RM8 | Solution NMR structure of PDLIM7 PDZ bound to SNX17 peptide | solution nmr | A | — | — |
| Q9NR12 | AlphaFold monomer V2.0 prediction for PDZ and lim domain protein 7 (Q9NR12) | predicted | A | — | 2 (best 0.67) |
Experiment against prediction
- 2Q3G chain B against the predicted model Q9NR12: TM-score 0.94, RMSD 1.34 Å
- 2Q3G chain B against the predicted model Q9NR12: TM-score 0.94, RMSD 1.34 Å
- 2Q3G chain A against the predicted model Q9NR12: TM-score 0.93, RMSD 1.31 Å
- 2Q3G chain A against the predicted model Q9NR12: TM-score 0.93, RMSD 1.31 Å
- 7RM8 chain A against the predicted model Q9NR12: TM-score 0.76, RMSD 2.70 Å
- 7RM8 chain A against the predicted model Q9NR12: TM-score 0.76, RMSD 2.70 Å
- 7RM8 chain A against the predicted model Q15036: TM-score 0.38, RMSD 4.64 Å
- 7RM8 chain A against the predicted model Q15036: TM-score 0.38, RMSD 4.64 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.